Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Hum Mutat. 2011 May;32(5):526-31. doi: 10.1002/humu.21454. Epub 2011 Apr 5.
In the area of pharmacogenetics and personalized health care it is obvious that databases, providing important information of the occurrence and consequences of variant genes encoding drug metabolizing enzymes, drug transporters, drug targets, and other proteins of importance for drug response or toxicity, are of critical value for scientists, physicians, and industry. The primary outcome of the pharmacogenomic field is the identification of biomarkers that can predict drug toxicity and drug response, thereby individualizing and improving drug treatment of patients. The drug in question and the polymorphic gene exerting the impact are the main issues to be searched for in the databases. Here, we review the databases that provide useful information in this respect, of benefit for the development of the pharmacogenomic field.
在药物遗传学和个性化医疗保健领域,提供有关变异基因编码药物代谢酶、药物转运蛋白、药物靶点和其他对药物反应或毒性有重要意义的蛋白质的发生和后果的重要信息的数据库对于科学家、医生和行业来说显然具有至关重要的价值。药物基因组学领域的主要成果是确定可以预测药物毒性和药物反应的生物标志物,从而实现患者用药的个体化和改善。有问题的药物和产生影响的多态性基因是数据库中需要搜索的主要问题。在这里,我们回顾了在这方面提供有用信息的数据库,这些数据库有助于药物基因组学领域的发展。